Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study, American Journal of Kidney Diseases, vol.31, issue.4 ,
DOI : 10.1053/ajkd.1998.v31.pm9531176
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis, Journal of the American Society of Nephrology, vol.15, issue.8, pp.2208-2218, 2004. ,
DOI : 10.1097/01.ASN.0000133041.27682.A2
Mortality Risk for Dialysis Patients With Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS), American Journal of Kidney Diseases, vol.52, issue.3, pp.519-530, 2008. ,
DOI : 10.1053/j.ajkd.2008.03.020
Involvement of Alpha-Klotho and Fibroblast Growth Factor Receptor in the Development of Secondary Hyperparathyroidism, American Journal of Nephrology, vol.31, issue.3, pp.230-238, 2010. ,
DOI : 10.1159/000274483
Interpretation of serum PTH concentrations with different kits in dialysis patients according to the KDIGO guidelines: importance of the reference (normal) values, Nephrology Dialysis Transplantation, vol.55, issue.9, pp.1950-1956, 2012. ,
DOI : 10.1373/clinchem.2008.121921
Parathyroid hormone measurement in CKD, Kidney International, vol.77, issue.2, pp.93-100, 2010. ,
DOI : 10.1038/ki.2009.374
Vitamin D and primary hyperparathyroidism (PHPT), Annales d'Endocrinologie, vol.73, issue.3, pp.165-169, 2012. ,
DOI : 10.1016/j.ando.2012.04.008
Contribution of calcium, phosphorus and 25-hydroxyvitamin D to the excessive severity of secondary hyperparathyroidism in African-Americans with CKD, Nephrology Dialysis Transplantation, vol.87, issue.7 ,
DOI : 10.1007/s00223-010-9397-5
Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients):1368?1376. 11. Gal-Moscovici A, Popovtzer MM. New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels, J. Bone Miner. Res. juin Clin. Nephrol. avr, vol.2663, issue.64, pp.284-289, 2005. ,
Actions of 1 alphahydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on mineral metabolism in man. I. Effects on net absorption of phosphorus):1064?1069. 14. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Kidney Int, 771?777. 13. Brickman AS, pp.1-130, 1977. ,
Chronic kidney disease: appropriateness of therapeutic management and associated factors in the AVENIR study, 121?8. 16. Ureña Torres P. What are the actual indications for a surgical parathiroidectomy, 2009. ,
DOI : 10.1111/j.1365-2753.2008.00965.x
KDIGO recommended values for bone and mineral metabolism in dialysis patients with uncontrollable secondary hyperparathyroidism, Langenbecks Arch Surg. mars, vol.397, issue.3, pp.413-420, 2012. ,
Meta-analysis of biochemical and patient-level effects of calcimimetic therapy The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism, Am. J. Kidney Dis. mai Clin J Am Soc Nephrol. janv, vol.473, issue.201, pp.36-45, 2006. ,
Les formes cliniques et biologiques de l???hyperparathyro??die secondaire en dialyse, N??phrologie & Th??rapeutique, vol.8, issue.1, pp.35-40, 2012. ,
DOI : 10.1016/j.nephro.2011.05.002
Long-term Management of CKD???Mineral and Bone Disorder, American Journal of Kidney Diseases, vol.60, issue.2 ,
DOI : 10.1053/j.ajkd.2012.01.027
Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism):513?518; discussion 518?519. 34. Pasieka JL, Parsons LL. A prospective surgical outcome study assessing the impact of parathyroidectomy on symptoms in patients with secondary and tertiary hyperparathyroidism Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism, Kidney Dis. août World J Surg. juin Surgery. oct World J Surg. août, vol.602212826, issue.358, pp.308-315, 1998. ,
Mesure de??la??qualit?? de??vie dans??l'insuffisance r??nale chronique terminale, N??phrologie & Th??rapeutique, vol.3, issue.6, pp.372-383, 2007. ,
DOI : 10.1016/j.nephro.2007.05.005
Cross-Validation of Item Selection and Scoring for the SF-12 Health Survey in Nine Countries, 1171?1178. 38 Multivariate descriptive statistical analysis, 1984. ,
DOI : 10.1016/S0895-4356(98)00109-7
COSMOS: the dialysis scenario of CKD-MBD in Europe Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS), sept Nephrol. Dial. Transplant. Nephrol. Dial. Transplant. janv Nephrol. Ther. sept, vol.122198, issue.1, pp.108-120, 1955. ,
Long-term outcome in patients with primary hyperparathyroidism who underwent minimally invasive parathyroidectomy The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10-year prospective surgical outcome study, 55?60. 45. Pasieka JL, Parsons, pp.1006-1013, 2009. ,
A study of the association of higher parathormone levels with health-related quality of life in hemodialysis patients, Clinical Nephrology, vol.77, issue.03, pp.196-203, 2012. ,
DOI : 10.5414/CN107030
Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism Prospective evaluation of quality of life (SF-36v2) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up) The Kidney, 153?159; discussion 159?160. 49. Noordzij M, 2005. ,
Mineral and bone disease pattern in elderly haemodialysis patients, Nephrology Dialysis Transplantation, vol.72, issue.9, pp.3062-3070, 2010. ,
DOI : 10.1038/sj.ki.5002466
The effectiveness and cost-effectiveness of cinacalcet for secondary hyperparathyroidism in end-stage renal disease patients on dialysis: a systematic review and economic evaluation, iii, xi?xiii, 1?167. 53. Naves-Díaz M, Passlick-Deetjen J, 2007. ,
DOI : 10.3310/hta11180
Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from ,
):1938?1947. 54. Perkovic V, Neal B. Trials in Kidney Disease -Time to EVOLVE, The CORES Study. Nephrol. Dial. Transplant. juin N. Engl. J. Med. 3 nov, vol.26, issue.6, 2011. ,